Delivery Order SPE2DB20D1100-SPE2DB25FD6F6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 30-count units, valued at $3,558.39. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award eligibility. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $7,327.31 delivery order to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion (30-count packages) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction under the company's broader federal medical...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $1,888.37 firm fixed price delivery order by the Defense Logistics Agency to supply 4561435008 CYCLOSPORINE 0.05% EYE EMULS 30S. The delivery order is being issued against an existing DLA contract vehicle and calls for Amerisourcebergen to deliver the specified pharmaceutical to a location in Conshohocken, Pennsylvania, with performance required between July 7-10, 2023. As the nation's largest...
- The Defense Logistics Agency awarded a $35,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 30 units of 0.05% cyclosporine ophthalmic emulsion. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The single day order is for an immunosuppressive drug commonly used to treat ocular surface disease and was issued under an existing DLA contract vehicle. As a leading pharmaceutical distributor, Amerisourcebergen will deliver...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclosporine 0.05% eye emulsion. The $2,181.63 contract has an ultimate completion date of December 5, 2022 and is part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a wide range of pharmaceuticals and medical supplies to support military...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Cyclosporine 0.05% eye emulsion in 30-count packages. The $1,107.10 contract has a completion date of February 20, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclosporine 0.05% eye emulsion. The contract is a firm-fixed-price delivery order worth $2,969.72, with a period of performance through September 27, 2024. AmerisourceBergen is the prime contractor and there is no set-aside designation mentioned. This order is likely part of a larger Indefinite Delivery Contract (IDC) between...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical for $1,502.70 to supply 4563117596 CYCLOSPORINE 0.05% EYE EMULS 60S. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by December 18, 2023. Issued against an indefinite delivery contract with no set-aside designation, this order supports DLA Troop Support Medical's provision of pharmaceuticals and...
- The Defense Logistics Agency awarded a $345.72 delivery order contract to Amerisourcebergen Drug Corporation to supply 30 units of 0.05% cyclosporine ophthalmic emulsion. The contract has a firm fixed price and period of performance from August 18, 2023 through August 21, 2023. Amerisourcebergen Drug Corporation will fulfill the order from its facility in Conshohocken, Pennsylvania. As a major provider of pharmaceuticals and medical supplies, Amerisourcebergen is well positioned through its...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for $2,366.16 to provide Cyclosporine 0.05% Eye Emulsion. The delivery order has a completion date of March 6, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD6F6Delivery Order
The Defense Logistics Agency awarded a $1,342.35 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion (30-count units). This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract specifies a place of performance in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters, with an ultimate completion date of July 25, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency and other government healthcare systems. The company's comprehensive pharmaceutical supply portfolio under its prime IDC vehicle encompasses brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs globally. This specific delivery order for ophthalmic medication is consistent with AmerisourceBergen's demonstrated capability to fulfill federal medical supply requirements through competitive procurement mechanisms and its extensive experience managing high-volume pharmaceutical distribution for defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/24/25 |